NAAG Challenges Efforts to Weaken Laws Against Human Trafficking & Sexual Abuse

December 9, 2021

The National Association of Attorneys General (NAAG) wrote a letter to the American Law Institute (ALI) urging them to reject proposed changes to Section 213 of the Model Penal Code (MPC) that would weaken the ability of states to prosecute sexual assault, abuse, exploitation, and trafficking crimes; jeopardize the safety of victims of these crimes;…

Read More →

Attorneys General Support Efforts to Stop Robocallers from Misusing Legitimate Phone Numbers

November 15, 2021

The National Association of Attorneys General (NAAG) today wrote the Federal Communications Commission (FCC) in support of its efforts to reduce illegal robocallers’ access to legitimate phone numbers to make unending robocalls that scam people out of their hard-earned money. The comment letter to the FCC was signed by all 50 state attorneys general and…

Read More →

NAAG Supports Senate Hearings on Social Media and Mental Health

October 5, 2021

As enforcers of our jurisdictions’ consumer protection laws, we find it deeply troubling that Facebook and other social media platforms seek to increase user engagement by conscripting our nation’s youth despite known harms to children and adolescents.

Read More →

Attorneys General Urge FCC to Accelerate Deadline for STIR/SHAKEN Adoption

August 9, 2021

The National Association of Attorneys General (NAAG) today urged the Federal Communications Commission (FCC) to fight back against the scourge of illegal robocalls by moving up the deadline for smaller telephone companies to implement caller ID technology. Under the TRACED Act, which became law in 2019, phone companies are required to implement STIR/SHAKEN technology on…

Read More →

Colorado et al. v. Google, No. 1:30-cv-03715 (D.D.C. Dec. 17, 2020)

July 12, 2021

Thirty-eight states sued Google, alleging that Google illegally maintains its monopoly power over general search engines and related general search advertising markets through a series of anticompetitive contracts and conduct, hurting both consumers and advertisers. Consumers are denied the benefits of competition, including the possibility of higher quality services and better privacy protections. Advertisers are…

Read More →

NAAG Submits Comment Letter on Beneficial Ownership Regulations

May 6, 2021

Our comments are consistent with the sense of Congress, which requires that regulations “to the greatest extent practicable… collect information in a form and manner that is reasonably designed to generate a database that is highly useful to… law enforcement agencies…” NDAA § 6402(8)(C).

Read More →

Attorneys General Urge Senate to Pass Law to Fight Shell Companies

October 26, 2020

As our States’ chief legal officers, we are concerned about the use of American financial institutions for money laundering by terrorist groups and other criminal enterprises.

Read More →

NAAG Endorses Stopping Overdoses of Fentanyl Analogues (SOFA) Act

October 22, 2020

States and localities are on the front line of this crisis and are a large part of winning the battle from both a law enforcement and public health perspective.

Read More →

Florida v. Abbott Laboratories and Geneva Pharmaceuticals, Inc.

October 9, 2020

The brand name maker of the prescription drug Hytrin, Abbott, entered into an agreement with Geneva to keep Geneva’s generic version of Hytrin off the market. Geneva was paid a substantial amount of money by Abbott while Abbott continued to collect monopoly profits on its name brand drug. Because of federal regulatory system for new generic entry, Geneva effectively blocked the entry of other generic drug makers. The matter settled in conjunction with MDL litigation.

Read More →

State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)

October 9, 2020

Plaintiff states alleged that the makers of Suboxone, a drug used to treat opioid addiction, engaged in a scheme to block generic competitors and raise prices. Specifically, they are conspiring to wtich Suboxone from a tablet version to a flim in order to prevent or delay generic entry. The states allege that the manufacturers engaged in “product hopping” in which a company makes slight changes to its product to extend patent protections and prvent generic alternatives. The complaint was filed under seal.

Read More →